Molecular characterization of a bladder pleomorphic rhabdomyosarcoma in an adult patient

Yang, 2014, Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma, BMC Cancer14, 654, 10.1186/1471-2407-14-654 Fletcher, 2013, Vol. 5 Sultan, 2009, Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients, J. Clin. Oncol., 27, 3391, 10.1200/JCO.2008.19.7483 Kam, 2018, Rapidly growing massive pleomorphic rhabdomyosarcoma of the bladder presenting with bladder outlet obstruction, ANZ J. Surg., 88, E208, 10.1111/ans.13319 Hama, 2004, Pleomorphic sarcoma of the adult urinary bladder: sonographic findings, J. Clin. Ultrasound, 32, 215, 10.1002/jcu.20011 Lauro, 1995, Rhabdomyosarcoma of the urinary bladder in an elderly patient, Anticancer Res., 15, 627 Takaoka, 2012, Multiple sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell line, Am. J. Cancer Res., 2, 141 Ayodele, 2020, Immunotherapy in soft-tissue sarcoma, Curr. Oncol., 27, 17, 10.3747/co.27.5407 Stout, 1946, Rhabdomyosarcoma of skeletal muscles, Ann Surg. Mar., 123, 447, 10.1097/00000658-194603000-00011 Li, 2009, Cytogenetic and real-time quantitative reverse-transcriptase polymerase chain reaction analyses in pleomorphic rhabdomyosarcoma, Cancer Genet. Cytogenet., 192, 1, 10.1016/j.cancergencyto.2009.02.011 Ortiz, 2017, Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma, PLoS One, 12, 10.1371/journal.pone.0188068 Vlenterie, 2016, Targeting cyclin-dependent kinases in synovial sarcoma: palbociclib as a potential treatment for synovial sarcoma patients, Ann. Surg. Oncol., 23, 2745, 10.1245/s10434-016-5341-x Italiano, 2009, Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas, Clin. Cancer Res., 15, 5696, 10.1158/1078-0432.CCR-08-3185 Pan, 2013, Epithelial growth factor receptor-activated nuclear factor kappaB signaling and its role in epithelial growth factor receptor-associated tumors, Cancer J., 19, 461, 10.1097/PPO.0000000000000001 Pan, 2016, The CBM complex underwrites NF-kappaB activation to promote HER2-associated tumor malignancy, Mol. Cancer Res., 14, 93, 10.1158/1541-7786.MCR-15-0229-T Pan, 2016, MALT1 is required for EGFR induced NF-κB activation and contributes to EGFR-driven lung cancer progression, Oncogene, 35, 919, 10.1038/onc.2015.146 Sanchez-Izquierdo, 2003, MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma, Blood, 101, 4539, 10.1182/blood-2002-10-3236 Rebeaud, 2008, The proteolytic activity of the paracaspase MALT1 is key in T cell activation, Nat. Immunol., 9, 272, 10.1038/ni1568 McAllister-Lucas, 2011, MALT1 protease: a new therapeutic target in B lymphoma and beyond, Clin. Cancer Res., 17, 6623, 10.1158/1078-0432.CCR-11-0467 Yeh, 2017, Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients, Oncotarget, 8, 113444, 10.18632/oncotarget.23049